Company · CIK 0001718108
Surface Oncology, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-23-231197 · 675.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-224961 · 204.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001718108-23-000019 · 5.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001718108-23-000017 · 253.4 KBSEC(opens sec.gov)
- SC 13GSurface Oncology, Inc.0001104659-23-082558 · 106.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-184004 · 149.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-181336 · 8.9 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-168488 · 1.4 MBSEC(opens sec.gov)
- 10-QQuarterly update0001718108-23-000013 · 6.0 MBSEC(opens sec.gov)
- 8-KCurrent report0001718108-23-000012 · 254.2 KBSEC(opens sec.gov)
Insiders
- Adams ChandraDeputy GC
- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- BARRETT M JAMES10% Owner
- BARRIS PETER J10% Owner
- BASKETT FOREST10% Owner
- Boni TheresaGeneral Counsel & Secretary
- Brunn CarstenDirector
- Chappel Scott CChief Technology Officer
Tickers
No tickers on record.
Addresses
business
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE, MA, 02139
mailing
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE, MA, 02139
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies